Mitoguazone

DB12967InvestigationalSmall molecule

Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

Chemical structure of Mitoguazone
Formula / weight
C5H12N8 · 184.2024 g/mol (avg)
Also known as
Me-GAG · Methyl-G

Resolves to

Compound
UNIIOD5Q0L447WCAS459-86-9ChEMBLCHEMBL216913ChEBI43996PubChem5351154
Clinical / RWD
ATCL01XX16
Structure
InChIKeyMXWHMTNPTTVWDM-NXOFHUPFSA-NSMILESC\C(\C=N\N=C(N)N)=N/N=C(N)N
Targets
P17707AMD1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mitoguazone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In